SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is surging as investors react to a new ceasefire agreement between the U.S. and Iran, with the community closely tracking the potential for renewed stability in global energy markets. Traders are currently focused on the asset's ability to hold critical support levels while reacting to institutional moves and increased spot market demand.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors react to the company's recent earnings report and the debut of Greg Abels leadership, with many discussing the firm's record cash reserves and the impact of the leadership transition on future capital allocation. The community remains divided, as some view the current price drop as a generational buying opportunity, while others express frustration over the lack of dividends and the stock's recent performance compared to the broader market.

Maulcoin

Maulcoin is capturing market attention as the community rallies behind an organic, grassroots movement focused on long-term growth and community-led milestones. Investors are actively discussing the project's resistance levels and potential for a breakout, emphasizing the importance of 'diamond hands' and avoiding the volatility common in typical short-term meme coin cycles.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is trending as supporters highlight its long-standing history dating back to 2011, contrasting it with newer, hype-driven meme coins. Community members are actively debating its potential to flip major assets while emphasizing the importance of utilizing the official contract address to avoid scams.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. (ALOY) is trending due to its pivotal role as a vertically integrated domestic rare earth provider, specifically driving momentum following a defense contract win and the appointment of high-profile national security figures to its board. The community is heavily focused on the company's strategic importance in bypassing Chinese supply chains ahead of 2027 defense procurement mandates, though sentiment remains divided between those betting on long-term industrial dominance and others raising concerns over share dilution and complex financing structures.

FLOKI is a community-driven, multi-chain utility token that powers a broad ecosystem including decentralized gaming, finance, and educational platforms. Originally evolving from a meme-based asset, the project now focuses on a utility-driven model centered around three pillars: community engagement, technical utility, and global charity work, balancing this ecosystem growth with social impact, such as building schools in developing nations like Ghana and Nigeria.  Key features include Valhalla, an NFT metaverse game where the token serves as the primary currency for capturing creatures and upgrading characters. The ecosystem also features the FlokiFi Locker for securing digital assets and the University of FLOKI for web3 education,with real-world integration facilitated through a prepaid debit card for everyday purchases at global stores. Staking FLOKI allows users to earn rewards in a sister token.  The project is led by a group of core advisors known by pseudonyms such as Sabre and B (The Viking) and is officially backed by DWF Labs, a major digital asset investment firm and market maker. While a small tax on decentralized trades helps fund development, value moves through the system as users utilize the token to pay for in-game items, access asset-locking services, or purchase merchandise.

Floki Token

Floki is capturing significant community attention as it expands its ecosystem with new ETP listings and advanced trading bot features while maintaining a strong narrative around its potential as a memecoin leader. Investors are actively debating its long-term growth trajectory and utility-driven milestones, frequently comparing its prospects and development pace to other major meme tokens.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is capturing investor interest as a distinct 'phygital' brand that bridges digital assets with large-scale retail presence in major physical stores and utility-focused partnerships like the Pengu Visa card. Community members are actively debating whether these fundamental growth catalysts and ecosystem expansion will eventually decouple the token from broader crypto market volatility and drive it to new heights.

Grok's first token launched on Base, deployed directly on X with help of Bankr. Proof of deployment here, https://x.com/grok/status/1897949874961650169.  Join the DRB community if this story intrigues you, follow it as it unfolds into this new AI era.  Grok earns swap fees - Grok's trading wallet: 0xb1058c959987e3513600eb5b4fd82aeee2a0e4f9.  Articles, media coverages on $DRB featured here, https://linktr.ee/DRBtaskforce.  Our dev, is grok, one of the front-running candidate to achieve AGI.

DebtReliefBot

DebtReliefBot (DRB) is surging in community sentiment as investors lean into the narrative that the token is tied to AI-driven wealth creation through its association with Grok and the Bankr ecosystem on Base. Proponents are actively highlighting its potential for significant growth, framing it as a sleeper pick and drawing comparisons to major meme coins while emphasizing the perceived utility and AI-innovation edge within the project.

NKN is building the largest blockchain for network sharing.

New Kind of Network

NKN is currently trending as speculative interest builds around potential partnership rumors and broader alt-season momentum, with the community actively debating whether the token is poised for a significant breakout or facing further downside. Investors are closely monitoring its price action and volume patterns, with many discussing its historical highs while navigating skepticism regarding its long-term viability and recent volatility.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility and renewed interest as market participants debate the impact of potential geopolitical shifts in the Middle East and the emerging discussion around the Clarity Act. The community remains deeply divided, with bulls pointing to institutional accumulation and ETF inflows, while skeptics emphasize the technical risks and the lingering uncertainty surrounding global macro conditions.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HCW Biologics Secures $7M Licensing Deal for Promising Immunotherapy

HCW Biologics (NASDAQ:HCWB) finalized an exclusive worldwide licensing agreement for its fusion immunotherapeutic candidate HCW11-006, marking a meaningful step in expanding its global development strategy.

Small Cap Stocks To Keep An Eye On - March 16th

CytomX Therapeutics, HCW Biologics, Direxion Daily MU Bull 2X Shares, Meiwu Technology, and AltC Acquisition are the five Small Cap stocks to watch today, according to MarketBeat's stock screener...

Promising Pharmaceutical Stocks To Keep An Eye On - March 16th

Eli Lilly and Company, CytomX Therapeutics, Pfizer, HCW Biologics, and AbbVie are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks...

Biotech Breakthroughs and Capital Moves Drive a Busy Market Week

A wave of biotech developments, strategic financings, and emerging-technology announcements shaped market narratives this week, highlighting how innovation across biopharma, AI-driven automation, energy technology, and crypto finance continues to drive investor attention. $CTMX, $NVDA, $HCWB, $KBLB, $CYN, $BMNR, $CLIK, $CIIT, $AIRS, $DFLI

<ul class="summary-bullets"><li>HCW Biologics stated that CAR-T cells manufactured with HCW9206 were significantly superior to those manufactured with standard methods.</li><li>The company said that CAR-Ts produced with its reagent are highly enriched in long-lived T memory stem cells.</li><li>HCW Biologics added that these CAR-Ts also displayed potent activity across distinct disease experimental models, namely, HIV-1 or B-cell leukemia.</li></ul>HCW Biologics Inc. (HCWB) shares soared more than 56% in Monday’s pre-market trade after the company announced positive research results for its CAR-T cell therapy.HCW Biologics stated that HCW9206, its proprietary, commercial-stage multi-cytokine fusion protein reagent, provides a new approach to generate CAR-T cells for immunotherapy with increased function at a cost-effective price.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/HCWB">HCW Biologics</a> trended in the ‘bullish’ territory with message volumes at ‘high’ levels.<h2 class="st-heading-2">HCW9206 CAR-Ts Outperform Standard Methods, Says Company</h2>HCW Biologics stated that CAR-T cells manufactured with HCW9206 were significantly superior to those manufactured with standard methods.The company said that CAR-Ts produced using its reagent are highly enriched in long-lived T-memory stem cells. HCW Biologics added that these CAR-Ts also displayed potent activity across distinct disease experimental models, namely, HIV-1 or B-cell leukemia.“Based on experimental models, HCW9206 has shown improvement in functional activities and persistence of CAR-Ts following adoptive transfer, a goal the industry has been trying to achieve for the last decade,” said HCW Biologics CEO, Dr. Hing C. Wong.The company stated that in its study, HCW9206 helped generate long-lasting duoCAR-T cells that showed strong HIV suppression in humanized mouse models using T cells from people living with HIV. The approach could extend CAR-T therapy durability and support efforts toward a functional HIV cure, it added.<h2 class="st-heading-2">Why Are CAR-T Cells Important?</h2>CAR-T cells represent a new way to treat cancer using the patient’s own immune system. These cells genetically modify a patient’s T cells so they can recognize and attack specific cancer cells, reducing damage to healthy tissue compared with traditional treatments.Additionally, once CAR-T cells are modified and infused into a patient’s body, they multiply and continue to fight cancer.<a href="https://stocktwits.com/symbol/HCWB">HCWB stock</a> is down 47% year-to-date and 96% over the past 12 months. The Vanguard Extended Market Index Fund ETF Shares (VXF) is up 20% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/soc-stock-soars-after-sable-resumes-oil-flow-from-california-pipeline/cZ32wB1RIfi">SOC Stock Rises Pre-Market After Energy Secretary Order Restarts Sable’s California Oil Pipeline</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

HCWB Stock Soars Pre-Market On Positive Research Results For CAR-T Cell Therapy

HCW Biologics said its proprietary multi-cytokine fusion protein reagent, HCW9206, offers a cost-effective way to generate higher-function CAR-T cells for immunotherapy.

Equity

Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7R, and Others  DelveInsight

Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7R, and Others | DelveInsight Alopecia Areata Market Set to...

HCW Biologics shares logged their best session in over three months on Monday after the firm revealed progress with a new cancer drug it thinks could be a multi-billion-dollar blockbuster.The stock jumped 60.8% to $5.55 on Monday, marking its best session since May 13, before adding another 0.5% in after-hours trading.The Florida-based biotech firm said it has developed an advanced form of pembrolizumab, which is sold by Merck as Keytruda and is considered the world’s top-selling FDA-approved immune checkpoint inhibitor.Drugs in this class are designed to help the immune system fight cancer, but they often only work for a small percentage of patients, and results are not always long-lasting.HCW Biologics said its version aims to go a step further: not only releasing the “brake” on the immune system but also activating immune cells and helping them infiltrate solid tumors, such as those seen in pancreatic and ovarian cancer.&nbsp;In early lab studies and mouse models, the company states that the therapy demonstrated stronger results than Keytruda alone, at dose levels that were well tolerated.CEO Hing C. Wong noted that global sales of checkpoint inhibitors topped $40 billion in 2024, underscoring the commercial potential if effectiveness can be improved.The company also sees potential for its therapy beyond cancer. HCW Biologics said checkpoint inhibitors may help clear “senescent” cells, which are aged cells that no longer divide but drive inflammation, making them a possible tool against age-related diseases.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 538% surge in 24-hour message volume, placing it among the most trending stocks on the platform.One user noted they had already taken profits, saying they made money on $HCWB and estimated early buyers likely gained 20–30%.<stembedurl>https://stocktwits.com/Camelinvesting/message/626495258</stembedurl>Another user praised HCW Biologics’ research, suggesting that since immune checkpoint inhibitors have shown success, improving on them could be the right path forward.<stembedurl>https://stocktwits.com/everything5/message/626494404</stembedurl><a href="https://stocktwits.com/symbol/HCWB">HCW Biologics’ stock</a> has declined 68.9% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

HCW Biologics (HCWB) shares logged their best session in over three months on Monday after the firm revealed progress with a new cancer drug it thinks could be a multi-billion-dollar blockbuster. | Image source: Getty Images

HCW Biologics Stock Scores Biggest Gain Since May As Cancer Drug Breakthrough Fuels Blockbuster Hopes

The biotech firm said its next-generation version of Keytruda showed stronger results in early studies and could eventually expand into both cancer and age-related disease treatments.

HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. The company was founded by Hing C. Wong on April 2, 2018 and is headquartered in Miramar, FL.

Current Price	$0.3645
Prev Close	$0.3373
Open	$0.3412
Dividend Yield	0.00%
50-Day Moving Average	$0.6471
Beta	0.37
Avg. Volume	22.78M
PE Ratio	-0.03

52-Week High	$17.80
52-Week Low	$0.25
Market Capitalization	$2.45M
EPS (Annual)	-$10.63
Price to Book	0.43
Revenue Per Employee	$1,549.49

HCWB
HCW Biologics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HCWB News

HCWBHCW Biologics Inc